Carregando...

Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context

Abstract Background Biomarkers such as amyloid imaging are increasingly used for diagnosis in the early stages of Alzheimer’s disease. Very few studies have examined this from the perspective of the patient. To date, there is only limited evidence about how patients experience and value disclosure i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Gwendolien Vanderschaeghe, Jolien Schaeverbeke, Rose Bruffaerts, Rik Vandenberghe, Kris Dierickx
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2017-12-01
coleção:Alzheimer’s Research & Therapy
Assuntos:
Acesso em linha:http://link.springer.com/article/10.1186/s13195-017-0321-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!